Patents by Inventor José MATALLO

José MATALLO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method, Computer Program and System for Analysing one or more Moving Objects in a Video
    Publication number: 20250069234
    Abstract: A method, being executed by a computer or signal processor or system or apparatus, for processing a first video data set comprising first video data of a first video depicting a plurality of moving objects. The method comprises generating one or more further video data sets from the first video data set, such that each further video data set of the one or more further video data sets comprises further video data of a further video, such that exactly one moving object of the plurality of moving objects is associated with said further video data set.
    Type: Application
    Filed: November 11, 2024
    Publication date: February 27, 2025
    Applicants: Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., Boehringer Ingelheim GmbH
    Inventors: Pinar BISGIN, Ole WERGER, Raphael BAIER, José MATALLO
  • USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF CARDIAC DISEASES IN NON-HUMAN MAMMALS EXCLUDING FELINES, IN PARTICULAR CANINES
    Publication number: 20240398845
    Abstract: The present invention is directed to the use of one or more SGLT-2 inhibitors or pharmaceutically acceptable forms thereof for the prophylaxis and/or treatment of one or more cardiac diseases in a non-human mammal/non-human mammal patient excluding a feline, in particular a canine/canine patient.
    Type: Application
    Filed: July 26, 2022
    Publication date: December 5, 2024
    Inventors: Carla KROH, Ingo Ulrich LANG, José MATALLO
  • COMBINATION TREATMENT AND/OR PREVENTION OF CARDIAC DISEASES IN NON-HUMAN MAMMALS COMPRISING ONE OR MORE SGLT-2 INHIBITORS AND PIMOBENDAN AND/OR TELMISARTAN
    Publication number: 20240390317
    Abstract: The present invention is directed to the use of one or more SGLT-2 inhibitors or pharmaceutically acceptable forms thereof in combination with pimobendan and/or telmisartan or pharmaceutically acceptable forms thereof, in particular for the prophylaxis and/or treatment of one or more cardiac diseases in a non-human mammal/non-human mammal patient, such as a dog or a cat.
    Type: Application
    Filed: May 17, 2024
    Publication date: November 28, 2024
    Inventors: Carla KROH, Ingo Ulrich LANG, José MATALLO, Tanja Margrit ZIMMERING
  • USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF RENAL DISEASES IN NON-HUMAN MAMMALS
    Publication number: 20240307426
    Abstract: The present invention is directed to the use of one or more SGLT-2 inhibitors or pharmaceutically acceptable forms thereof for the prophylaxis and/or treatment of one or more renal diseases in a non-human mammal, such as a carnivore, in particular a cat or a dog.
    Type: Application
    Filed: July 26, 2022
    Publication date: September 19, 2024
    Inventors: Carla KROH, Ingo Ulrich LANG, José MATALLO
  • USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF HYPERTENSION IN NON-HUMAN MAMMALS
    Publication number: 20240269105
    Abstract: The present invention is directed to the use of one or more SGLT-2 inhibitors or pharmaceutically acceptable forms thereof for the prophylaxis and/or treatment of hypertension in a non-human mammal, preferably a carnivore, in particular a cat or a dog.
    Type: Application
    Filed: July 26, 2022
    Publication date: August 15, 2024
    Inventors: José MATALLO, Carla KROH, Christoph Matthias SCHUMMER